The 3rd Annual Epigenetic–Targeted Drug Discovery & Development Summit offers an unrivaled opportunity to leverage over 5 hours of dedicated networking opportunities with key industry decision-makers leading the epigenetic therapeutics space.
We’ll work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your 2022 commercial objectives.
Meet and network with key-decision makers on how your expertise can help ensure epigenetic therapies achieve their full potential and reach patients in need
Secure a branding or speaking opportunity to demonstrate your thought leadership, drive your brand exposure and differentiate yourself from competitors
Leverage the two 'speed-networking' sessions to facilitate lead generation and build new relationships with senior level decision-makers from leading pharma and biotech companies
Secure an exhibition booth to showcase your expertise and educate the industry on how you can support and streamline their efforts